{"title":"블로터 ─ 비즈니스 ─ 헤드라인","url":"https://www.bloter.net/section?id=sectionBusiness2","favicon":"https://www.bloter.net/favicon.png","elements":[{"title":"안다자산운용의 '저평가 지주사' 투자법...'알짜 자회사' 보유한 SK케미칼 노렸다","contents":"<span class=\"writer\">구태우</span>                        <span class=\"date\">2022-08-09 15:30:59</span>","link":"https://www.bloter.net/newsView/blt202208090010","retrieved":1660029377499,"image":"https://www.bloter.net/data/blt/image/2022/08/09/blt202208090015.570x320.0.jpg"},{"title":"SK케미칼 ‘기넥신’의 30년, 앞으로 꽃길이 기대되는 이유","contents":"<span class=\"writer\">안치영</span>                        <span class=\"date\"></span>","link":"https://www.bloter.net/newsView/blt202207060010","retrieved":1660029377505},{"title":"SK케미칼이 ‘AI 신약 개발’로 노리는 것","contents":"<span class=\"writer\">정두용</span>                        <span class=\"date\"></span>","link":"https://www.bloter.net/newsView/blt202204280140","retrieved":1660029377507},{"title":"SK케미칼, AI로 신약 발굴 ‘5년→1년’…개방형 전략 효과 입증","contents":"<span class=\"writer\">정두용</span>                        <span class=\"date\"></span>","link":"https://www.bloter.net/newsView/blt202201270218","retrieved":1660029377508},{"title":"SK케미칼, 신약개발 전담 조직 만든다…“오픈 R&D 확대”","contents":"<span class=\"writer\">정두용</span>                        <span class=\"date\"></span>","link":"https://www.bloter.net/newsView/blt202201190053","retrieved":1660029377510}]}